Evotec nine — month adjusted EBITDA loss narrows to EUR 42.8 million; revenue rises to EUR 465 million
Evotec posted preliminary nine-month 2026 revenue of about €465 million, topping market expectations. Adjusted Group EBITDA was about -€42.8 million for the period, also above consensus. The company said the variance versus expectations largely related to the phasing of consensus estimates. Evotec reaffirmed full-year 2026 revenue guidance of about €570 million to €610 million. It maintained adjusted Group EBITDA guidance of about -€70 million to -€105 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evotec SE published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2415242_en) on October 13, 2026, and is solely responsible for the information contained therein. (C)
Evotec posted preliminary nine-month 2026 revenue of about €465 million, topping market expectations. 8 million for the period, also above consensus. The company said the variance versus expectations largely related to the phasing of consensus estimates. Evotec reaffirmed full-year 2026 revenue guidance of about €570 million to €610 million.
It maintained adjusted Group EBITDA guidance of about -€70 million to -€105 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evotec SE published the original content used to generate this news brief via EQS News (Ref.
ID: adhoc_2415242_en) on October 13, 2026, and is solely responsible for the information contained therein. (C)